KEGG analysis revealed notably enriched pathways, including PI3K-AKT, MAPK, Ras, JAK-STAT, acute myeloid leukemia, EGFR tyrosine kinase inhibitors, and endocrine resistance (Supplementary Figure S2B). This evidence concerns the gene AKT1 and acute myeloid leukemia.